Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus Infections | 33 | 2026 | 395 | 4.720 |
Why?
|
| Respiratory Syncytial Virus, Human | 28 | 2026 | 241 | 4.580 |
Why?
|
| Nasal Mucosa | 3 | 2026 | 88 | 1.900 |
Why?
|
| Viral Load | 9 | 2025 | 407 | 1.800 |
Why?
|
| Organoids | 4 | 2025 | 301 | 1.630 |
Why?
|
| Cytokines | 3 | 2025 | 1344 | 1.180 |
Why?
|
| Virus Replication | 8 | 2026 | 607 | 1.070 |
Why?
|
| Respiratory Tract Infections | 7 | 2025 | 297 | 1.030 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 7 | 2026 | 82 | 1.020 |
Why?
|
| Respiratory Syncytial Viruses | 5 | 2025 | 153 | 0.870 |
Why?
|
| RNA, Viral | 8 | 2024 | 499 | 0.860 |
Why?
|
| Viral Fusion Proteins | 9 | 2023 | 74 | 0.770 |
Why?
|
| Antibodies, Viral | 15 | 2026 | 1174 | 0.770 |
Why?
|
| Bacterial Adhesion | 3 | 2007 | 104 | 0.710 |
Why?
|
| Picornaviridae Infections | 4 | 2025 | 49 | 0.700 |
Why?
|
| Transplant Recipients | 3 | 2021 | 228 | 0.660 |
Why?
|
| Respiratory Mucosa | 3 | 2020 | 93 | 0.600 |
Why?
|
| Haemophilus influenzae | 4 | 2007 | 134 | 0.580 |
Why?
|
| Immunity, Innate | 5 | 2025 | 410 | 0.580 |
Why?
|
| Influenza, Human | 7 | 2024 | 702 | 0.540 |
Why?
|
| Bronchiolitis | 4 | 2021 | 126 | 0.500 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2021 | 1273 | 0.490 |
Why?
|
| Genome, Viral | 4 | 2025 | 167 | 0.480 |
Why?
|
| Virus Diseases | 4 | 2022 | 286 | 0.470 |
Why?
|
| Host-Pathogen Interactions | 3 | 2025 | 253 | 0.470 |
Why?
|
| Epithelial Cells | 5 | 2026 | 907 | 0.470 |
Why?
|
| Viral Tropism | 2 | 2026 | 55 | 0.450 |
Why?
|
| Hospitalization | 9 | 2025 | 1933 | 0.420 |
Why?
|
| Antibodies, Neutralizing | 8 | 2026 | 526 | 0.400 |
Why?
|
| Humans | 66 | 2026 | 130441 | 0.390 |
Why?
|
| Rhinovirus | 3 | 2025 | 67 | 0.380 |
Why?
|
| Enterovirus Infections | 2 | 2024 | 47 | 0.370 |
Why?
|
| Viruses | 3 | 2024 | 115 | 0.350 |
Why?
|
| Infant | 20 | 2026 | 13228 | 0.350 |
Why?
|
| Phenotype | 1 | 2021 | 4472 | 0.340 |
Why?
|
| Seasons | 5 | 2024 | 333 | 0.330 |
Why?
|
| Genotype | 8 | 2025 | 2589 | 0.330 |
Why?
|
| Influenza A virus | 2 | 2015 | 142 | 0.330 |
Why?
|
| Immunity, Humoral | 2 | 2021 | 73 | 0.330 |
Why?
|
| Adult | 19 | 2026 | 31121 | 0.310 |
Why?
|
| Sindbis Virus | 1 | 2009 | 10 | 0.310 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2022 | 166 | 0.310 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 525 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2006 | 125 | 0.290 |
Why?
|
| Virus Shedding | 4 | 2021 | 75 | 0.280 |
Why?
|
| Streptococcus pneumoniae | 2 | 2007 | 389 | 0.270 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 776 | 0.260 |
Why?
|
| Female | 28 | 2026 | 70354 | 0.260 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2006 | 12 | 0.240 |
Why?
|
| Kinetics | 2 | 2025 | 1084 | 0.240 |
Why?
|
| Male | 23 | 2026 | 64473 | 0.230 |
Why?
|
| Nucleosides | 1 | 2025 | 18 | 0.230 |
Why?
|
| Adenoviruses, Human | 1 | 2025 | 97 | 0.220 |
Why?
|
| Immunity, Mucosal | 2 | 2025 | 97 | 0.220 |
Why?
|
| Influenza Vaccines | 2 | 2023 | 501 | 0.220 |
Why?
|
| Adenovirus Infections, Human | 1 | 2025 | 61 | 0.220 |
Why?
|
| Nose | 1 | 2025 | 114 | 0.210 |
Why?
|
| Texas | 5 | 2023 | 3643 | 0.210 |
Why?
|
| Genetic Variation | 4 | 2025 | 1541 | 0.210 |
Why?
|
| Antigens, Viral | 3 | 2024 | 391 | 0.210 |
Why?
|
| Liposomes | 1 | 2025 | 197 | 0.210 |
Why?
|
| Antiviral Agents | 3 | 2025 | 801 | 0.210 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 60 | 0.200 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 793 | 0.200 |
Why?
|
| Immunoglobulin A | 2 | 2021 | 205 | 0.200 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2024 | 16 | 0.200 |
Why?
|
| Pandemics | 6 | 2024 | 1157 | 0.200 |
Why?
|
| Acetamides | 1 | 2024 | 43 | 0.200 |
Why?
|
| Enterovirus | 1 | 2024 | 51 | 0.200 |
Why?
|
| Poliovirus | 1 | 2023 | 47 | 0.200 |
Why?
|
| Disease Outbreaks | 2 | 2023 | 314 | 0.200 |
Why?
|
| Up-Regulation | 1 | 2006 | 827 | 0.200 |
Why?
|
| Phylogeny | 5 | 2025 | 687 | 0.190 |
Why?
|
| Prospective Studies | 9 | 2026 | 6424 | 0.190 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 278 | 0.190 |
Why?
|
| Cell Line | 5 | 2023 | 2557 | 0.190 |
Why?
|
| Child, Preschool | 13 | 2025 | 14944 | 0.190 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 286 | 0.190 |
Why?
|
| Lung | 3 | 2025 | 1534 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 352 | 0.180 |
Why?
|
| Norovirus | 1 | 2025 | 284 | 0.180 |
Why?
|
| Palivizumab | 2 | 2021 | 48 | 0.180 |
Why?
|
| Enterovirus D, Human | 1 | 2021 | 11 | 0.180 |
Why?
|
| Coinfection | 2 | 2021 | 185 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2026 | 567 | 0.180 |
Why?
|
| Respiratory Tract Diseases | 1 | 2022 | 81 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 1693 | 0.170 |
Why?
|
| Viral Structural Proteins | 1 | 2021 | 39 | 0.170 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 42 | 0.160 |
Why?
|
| Child | 15 | 2025 | 26098 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 353 | 0.160 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1485 | 0.160 |
Why?
|
| Respiratory Sounds | 1 | 2021 | 78 | 0.160 |
Why?
|
| Middle Aged | 7 | 2025 | 28395 | 0.150 |
Why?
|
| Vaccination | 3 | 2026 | 1051 | 0.150 |
Why?
|
| Haemophilus | 1 | 2019 | 13 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2021 | 393 | 0.150 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 155 | 0.150 |
Why?
|
| Cities | 3 | 2024 | 51 | 0.150 |
Why?
|
| Orthomyxoviridae | 1 | 2019 | 49 | 0.150 |
Why?
|
| Laboratories | 1 | 2019 | 79 | 0.140 |
Why?
|
| Adolescent | 9 | 2025 | 20727 | 0.140 |
Why?
|
| Young Adult | 5 | 2021 | 9993 | 0.140 |
Why?
|
| Cross Infection | 1 | 2021 | 333 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 282 | 0.130 |
Why?
|
| Genes, Viral | 1 | 2017 | 155 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 540 | 0.130 |
Why?
|
| CHO Cells | 2 | 2007 | 151 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 502 | 0.120 |
Why?
|
| Cricetinae | 2 | 2007 | 361 | 0.120 |
Why?
|
| Infant, Newborn | 7 | 2026 | 8520 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2019 | 327 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 351 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 363 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2551 | 0.110 |
Why?
|
| Influenza B virus | 1 | 2015 | 102 | 0.110 |
Why?
|
| United States | 7 | 2025 | 11874 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1367 | 0.110 |
Why?
|
| Mutation | 2 | 2024 | 6098 | 0.110 |
Why?
|
| Bodily Secretions | 1 | 2014 | 8 | 0.110 |
Why?
|
| Animals | 9 | 2025 | 33857 | 0.110 |
Why?
|
| Nasopharynx | 3 | 2019 | 88 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 61 | 0.110 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 2397 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 192 | 0.100 |
Why?
|
| Aged | 5 | 2021 | 20888 | 0.100 |
Why?
|
| Caspases | 1 | 2014 | 152 | 0.100 |
Why?
|
| Microbiota | 1 | 2019 | 438 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 583 | 0.100 |
Why?
|
| Alphavirus | 1 | 2013 | 17 | 0.100 |
Why?
|
| Sigmodontinae | 2 | 2025 | 45 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 37 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 310 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6788 | 0.090 |
Why?
|
| Acute Disease | 2 | 2025 | 1150 | 0.090 |
Why?
|
| Cattle | 2 | 2024 | 502 | 0.090 |
Why?
|
| Epidemiological Monitoring | 2 | 2024 | 72 | 0.090 |
Why?
|
| Antibody Formation | 2 | 2021 | 227 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 1456 | 0.080 |
Why?
|
| Insect Viruses | 1 | 2009 | 5 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3469 | 0.080 |
Why?
|
| Organisms, Genetically Modified | 1 | 2009 | 10 | 0.080 |
Why?
|
| Disease Vectors | 1 | 2009 | 22 | 0.080 |
Why?
|
| Haemophilus Infections | 2 | 2007 | 97 | 0.070 |
Why?
|
| Pregnancy | 4 | 2026 | 7395 | 0.070 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3798 | 0.070 |
Why?
|
| Molecular Typing | 2 | 2021 | 32 | 0.070 |
Why?
|
| Drosophila | 1 | 2013 | 772 | 0.070 |
Why?
|
| Virulence | 2 | 2006 | 271 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2006 | 116 | 0.070 |
Why?
|
| Cricetulus | 1 | 2007 | 89 | 0.070 |
Why?
|
| Islam | 1 | 2006 | 11 | 0.060 |
Why?
|
| Arabs | 1 | 2006 | 29 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2006 | 1016 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2006 | 52 | 0.060 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 29 | 0.060 |
Why?
|
| Mucins | 1 | 2006 | 71 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2018 | 732 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 84 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2025 | 57 | 0.060 |
Why?
|
| Pneumococcal Infections | 1 | 2007 | 280 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2025 | 130 | 0.060 |
Why?
|
| Haplotypes | 1 | 2006 | 517 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 224 | 0.050 |
Why?
|
| Livestock | 1 | 2024 | 11 | 0.050 |
Why?
|
| Age Factors | 2 | 2025 | 2827 | 0.050 |
Why?
|
| Farmers | 1 | 2024 | 13 | 0.050 |
Why?
|
| Adenosine | 1 | 2025 | 118 | 0.050 |
Why?
|
| Birds | 1 | 2024 | 49 | 0.050 |
Why?
|
| Influenza in Birds | 1 | 2024 | 27 | 0.050 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 56 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 18 | 0.050 |
Why?
|
| Mutation Rate | 1 | 2024 | 68 | 0.050 |
Why?
|
| Transfection | 1 | 2006 | 960 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2006 | 411 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 837 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2006 | 766 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1807 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 294 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 1656 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2025 | 393 | 0.050 |
Why?
|
| Bacterial Capsules | 1 | 2003 | 42 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2025 | 708 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2025 | 308 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2024 | 364 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2025 | 977 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 74 | 0.050 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2022 | 35 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3355 | 0.050 |
Why?
|
| Coronavirus | 1 | 2022 | 28 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2088 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2023 | 126 | 0.050 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2023 | 128 | 0.050 |
Why?
|
| Paramyxoviridae Infections | 1 | 2022 | 49 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 47 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 195 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2021 | 50 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2025 | 299 | 0.040 |
Why?
|
| Peripartum Period | 1 | 2022 | 28 | 0.040 |
Why?
|
| Turbinates | 1 | 2021 | 12 | 0.040 |
Why?
|
| Water | 1 | 2023 | 185 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2024 | 417 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2021 | 38 | 0.040 |
Why?
|
| Gene Expression | 1 | 2006 | 1486 | 0.040 |
Why?
|
| Species Specificity | 1 | 2022 | 474 | 0.040 |
Why?
|
| Fever | 1 | 2024 | 311 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 411 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2021 | 198 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 140 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2024 | 645 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 425 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 272 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2896 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 3030 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2894 | 0.040 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 2020 | 9 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2020 | 37 | 0.040 |
Why?
|
| Half-Life | 1 | 2020 | 148 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 48 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 731 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 144 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 6201 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 263 | 0.040 |
Why?
|
| RNA Stability | 1 | 2020 | 75 | 0.040 |
Why?
|
| DNA Probes | 1 | 2019 | 118 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 74 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 160 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 805 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2024 | 797 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1115 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 704 | 0.030 |
Why?
|
| DNA Primers | 1 | 2019 | 600 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3717 | 0.030 |
Why?
|
| Allografts | 1 | 2019 | 218 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2464 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1206 | 0.030 |
Why?
|
| Chile | 1 | 2017 | 25 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 1388 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 2017 | 37 | 0.030 |
Why?
|
| Genomics | 1 | 2025 | 1618 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1472 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 344 | 0.030 |
Why?
|
| Child, Hospitalized | 1 | 2017 | 77 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 89 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 404 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 228 | 0.030 |
Why?
|
| Nasal Cavity | 1 | 2015 | 56 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 2016 | 149 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 612 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 524 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 147 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4667 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5034 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3313 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2013 | 223 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 978 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3676 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1219 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2289 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 4035 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 18229 | 0.020 |
Why?
|
| Geography | 1 | 2006 | 114 | 0.020 |
Why?
|
| Asia | 1 | 2006 | 125 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 204 | 0.010 |
Why?
|
| India | 1 | 2006 | 233 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2006 | 177 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 4861 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3386 | 0.010 |
Why?
|
| Fimbriae Proteins | 1 | 2003 | 20 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 203 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1374 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10949 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 173 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 480 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 17514 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 944 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 2683 | 0.010 |
Why?
|